Dose effect relationship in breast cancer

This publication has 30 references indexed in Scilit:

• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
  The Lancet, 1992
• Dose intensity as a therapeutic strategy in breast cancer
  Breast Cancer Research and Treatment, 1991
• Effects of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Myelosuppression induced by Multiple Cycles of High-Dose Chemotherapy in Patients With Advanced Breast Cancer
  JNCI Journal of the National Cancer Institute, 1991
• Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor
  Blood, 1989
• Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and Strategies
  JNCI Journal of the National Cancer Institute, 1989
• A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma
  British Journal of Cancer, 1987
• Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer
  Breast Cancer Research and Treatment, 1985
• Increasing therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology
  Pharmacology & Therapeutics, 1983
• Dose-Response Effect of Adjuvant Chemotherapy in Breast Cancer
  New England Journal of Medicine, 1981
• Dose: A critical factor in cancer chemotherapy
  The American Journal of Medicine, 1980